Seamless seals $1.12B gene editing deal with Lilly on hearing loss
Seamless seals $1.12B gene editing deal with Lilly on hearing loss
Seamless seals $1.12B gene editing deal with Lilly on hearing loss
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.